Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Ocular Therapeutix, Inc. OCUL

Set alert

Price alert · OCUL

All alert types
6.73 USD -0.24 -3.44%

At close · Nov 2

6.73 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
6.73 × 2
Ask
6.74 × 2
6.58 Day range 7.03
6.00 52-week range 16.44
YTD
-44.56%
1 year
-42.28%
Open
6.97
Prev close
6.97
Mkt cap
1.48B
Vol
1.88M
Avg vol
3.06M
EPS
-1.40
P/E
0.00
Div yield
0.00%
More statistics
Low
6.58
High
7.03
Forward P/E
-4.55
Beta
1.22
Short ratio
7.60
Inst. own
95.31%
Dividend
0.00
Ex-div date
Earnings
Nov 3, 2026
50-d avg
8.81
200-d avg
9.12
1y target
25.45

MAX chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Aug 5, 2025Earnings: -0.39; estimate -0.35; surprise -11.43%
  • Nov 4, 2025Earnings: -0.37; estimate -0.39; surprise 5.13%
  • Feb 5, 2026Earnings: -0.29; estimate -0.33; surprise 12.12%
  • May 5, 2026Earnings: -0.41; estimate -0.32; surprise -28.12%
  • Aug 3, 2026Earnings: -0.35; estimate -0.39545; surprise 11.49%
  • Oct 2, 2026Rating: Chardan Capital · Buy → Buy
Signals (43)
NameDateAgo
SMA: BearishSep 1, 20262 months ago
SMA: BearishSep 1, 20262 months ago
SMA: BullishAug 1, 20263 months ago
SMA: BullishAug 1, 20263 months ago
SMA: BearishJul 1, 20264 months ago
MACD: Sell SignalFeb 1, 20269 months ago
SMA: BearishJan 1, 202610 months ago
SMA: BullishJun 1, 20251 year ago
SMA: BearishJan 1, 20251 year ago
SMA: BullishMay 1, 20242 years ago
SMA: BullishMay 1, 20242 years ago
SMA: BearishApr 1, 20242 years ago
SMA: BearishApr 1, 20242 years ago
SMA: BullishFeb 1, 20242 years ago
SMA: BullishDec 1, 20232 years ago
MACD: Buy SignalDec 1, 20232 years ago
MACD: Sell SignalNov 1, 20233 years ago
SMA: BearishJul 1, 20233 years ago
MACD: Buy SignalMar 1, 20233 years ago
SMA: BullishJan 1, 20233 years ago
SMA: BearishSep 1, 20224 years ago
SMA: BullishAug 1, 20224 years ago
SMA: BearishOct 1, 20215 years ago
MACD: Sell SignalAug 1, 20215 years ago
SMA: BearishMay 1, 20215 years ago
RSI: OverboughtNov 1, 20206 years ago
SMA: BullishMar 1, 20206 years ago
SMA: BullishNov 1, 20197 years ago
SMA: BearishSep 1, 20197 years ago
SMA: BullishJul 1, 20197 years ago
SMA: BearishDec 1, 20187 years ago
SMA: BullishNov 1, 20188 years ago
SMA: BearishOct 1, 20188 years ago
SMA: BullishAug 1, 20188 years ago
SMA: BearishJul 1, 20188 years ago
SMA: BullishMar 1, 20188 years ago
SMA: BearishJul 1, 20179 years ago
SMA: BullishFeb 1, 20179 years ago
SMA: BearishJan 1, 20179 years ago
SMA: BullishNov 1, 201610 years ago
SMA: BearishJun 1, 201610 years ago
SMA: BullishApr 1, 201610 years ago
SMA: BearishJun 1, 201511 years ago

Financial health

Altman Z-Score

2.82 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 2

Valuation

P/E -8.5×
FY 2016: -4.6×FY 2017: -2.0×FY 2018: -2.5×FY 2019: -2.1×FY 2020: -8.1×FY 2021: -6.6×FY 2022: -2.7×FY 2023: -4.1×FY 2024: -7.0×FY 2025: -8.5×
FY 2016 5y median -6.6× FY 2025
P/S 43.9×
FY 2016: 110×FY 2017: 66.7×FY 2018: 76.2×FY 2019: 42.3×FY 2020: 72.3×FY 2021: 12.2×FY 2022: 4.2×FY 2023: 6.1×FY 2024: 21.2×FY 2025: 43.9×
FY 2016 5y median 12.2× FY 2025
P/B 3.5×
FY 2016: 4.0×FY 2017: 4.9×FY 2018: 4.2×FY 2019: -49.3×FY 2020: 16.5×FY 2021: 6.1×FY 2022: 6.1×FY 2023: 3.9×FY 2024: 4.3×FY 2025: 3.5×
FY 2016 5y median 4.3× FY 2025
P/FCF -10.5×
FY 2016: -5.8×FY 2017: -2.2×FY 2018: -3.0×FY 2019: -2.2×FY 2020: -23.1×FY 2021: -8.0×FY 2022: -3.4×FY 2023: -4.7×FY 2024: -9.9×FY 2025: -10.5×
FY 2016 5y median -8.0× FY 2025
EV/EBITDA -6.5×
FY 2016: -4.5×FY 2017: -1.7×FY 2018: -2.2×FY 2019: -2.4×FY 2020: -7.4×FY 2021: 168×FY 2022: -2.9×FY 2023: -3.7×FY 2024: -5.9×FY 2025: -6.5×
FY 2016 5y median -3.7× FY 2025
EV/Sales 31.2×
FY 2016: 101×FY 2017: 54.5×FY 2018: 61.5×FY 2019: 43.5×FY 2020: 62.5×FY 2021: 9.8×FY 2022: 3.5×FY 2023: 4.2×FY 2024: 16.2×FY 2025: 31.2×
FY 2016 5y median 9.8× FY 2025
FCF Yield -9.5%
FY 2016: -17.3%FY 2017: -45.8%FY 2018: -33.7%FY 2019: -44.6%FY 2020: -4.3%FY 2021: -12.5%FY 2022: -29.3%FY 2023: -21.4%FY 2024: -10.1%FY 2025: -9.5%
FY 2016 5y median -12.5% FY 2025

Profitability

Gross Margin 87.3%
FY 2016: 76.5%FY 2017: 76.2%FY 2018: 76.6%FY 2019: 45.0%FY 2020: 88.0%FY 2021: 89.9%FY 2022: 91.2%FY 2023: 91.0%FY 2024: 91.2%FY 2025: 87.3%
FY 2016 5y median 91.0% FY 2025
Operating Margin -521.0%
FY 2016: -2296.0%FY 2017: -3220.1%FY 2018: -2970.8%FY 2019: -2029.9%FY 2020: -361.1%FY 2021: -179.3%FY 2022: -152.7%FY 2023: -141.0%FY 2024: -269.6%FY 2025: -521.0%
FY 2016 5y median -179.3% FY 2025
Net Margin -513.2%
FY 2016: -2369.0%FY 2017: -3296.2%FY 2018: -2899.1%FY 2019: -2043.3%FY 2020: -894.3%FY 2021: -15.1%FY 2022: -138.0%FY 2023: -138.1%FY 2024: -303.7%FY 2025: -513.2%
FY 2016 5y median -138.1% FY 2025
ROE -40.6%
FY 2016: -86.0%FY 2017: -242.4%FY 2018: -160.8%FY 2019: 2379.4%FY 2020: -204.5%FY 2021: -7.4%FY 2022: -200.8%FY 2023: -88.6%FY 2024: -61.4%FY 2025: -40.6%
FY 2016 5y median -61.4% FY 2025
ROIC -35.5%
FY 2016: -63.5%FY 2017: -130.2%FY 2018: -89.0%FY 2019: -126.5%FY 2020: -25.7%FY 2021: -43.3%FY 2022: -65.8%FY 2023: -37.7%FY 2024: -41.0%FY 2025: -35.5%
FY 2016 5y median -41.0% FY 2025
ROA -32.9%
FY 2016: -59.7%FY 2017: -114.4%FY 2018: -79.0%FY 2019: -109.7%FY 2020: -59.4%FY 2021: -3.2%FY 2022: -47.6%FY 2023: -32.0%FY 2024: -42.3%FY 2025: -32.9%
FY 2016 5y median -32.9% FY 2025

Growth (YoY)

Revenue -18.7%
FY 2016: 7.8%FY 2017: 1.9%FY 2018: 3.5%FY 2019: 112.4%FY 2020: 311.7%FY 2021: 150.1%FY 2022: 18.3%FY 2023: 13.5%FY 2024: 9.0%FY 2025: -18.7%
FY 2016 FY 2025
Operating Income -57.2%
FY 2016: -13.4%FY 2017: -42.9%FY 2018: 4.5%FY 2019: -45.1%FY 2020: 26.8%FY 2021: -24.2%FY 2022: -0.8%FY 2023: -4.7%FY 2024: -108.5%FY 2025: -57.2%
FY 2016 FY 2025
EPS (diluted) -16.4%
FY 2016: -5.3%FY 2017: -22.2%FY 2018: 28.6%FY 2019: -21.7%FY 2020: -34.0%FY 2021: 61.7%FY 2022: 1.0%FY 2023: -5.2%FY 2024: -19.6%FY 2025: -16.4%
FY 2016 FY 2025
Free Cash Flow -59.5%
FY 2016: -1.1%FY 2017: -63.5%FY 2018: 13.0%FY 2019: -56.1%FY 2020: 31.8%FY 2021: -22.7%FY 2022: 5.1%FY 2023: -20.5%FY 2024: -78.1%FY 2025: -59.5%
FY 2016 FY 2025

Financial Health

Current Ratio 15.4×
FY 2016: 8.4×FY 2017: 3.2×FY 2018: 6.1×FY 2019: 5.0×FY 2020: 9.2×FY 2021: 7.3×FY 2022: 4.1×FY 2023: 6.7×FY 2024: 10.7×FY 2025: 15.4×
FY 2016 5y median 7.3× FY 2025
Quick Ratio 15.3×
FY 2016: 8.4×FY 2017: 3.2×FY 2018: 6.1×FY 2019: 4.9×FY 2020: 9.2×FY 2021: 7.2×FY 2022: 4.1×FY 2023: 6.6×FY 2024: 10.6×FY 2025: 15.3×
FY 2016 5y median 7.2× FY 2025
Debt / Equity 0.1×
FY 2016: 0.3×FY 2017: 0.7×FY 2018: 0.7×FY 2019: -16.3×FY 2020: 0.8×FY 2021: 0.7×FY 2022: 1.8×FY 2023: 0.9×FY 2024: 0.2×FY 2025: 0.1×
FY 2016 5y median 0.7× FY 2025
Net Debt / EBITDA 2.6×
FY 2016: 0.4×FY 2017: 0.4×FY 2018: 0.5×FY 2019: -0.1×FY 2020: 1.2×FY 2021: -41.4×FY 2022: 0.6×FY 2023: 1.7×FY 2024: 1.8×FY 2025: 2.6×
FY 2016 5y median 1.7× FY 2025
Interest Coverage -22.8×
FY 2016: -25.8×FY 2017: -32.7×FY 2018: -34.0×FY 2019: -14.1×FY 2020: -9.3×FY 2021: -11.7×FY 2022: -11.2×FY 2023: -7.3×FY 2024: -12.7×FY 2025: -22.8×
FY 2016 5y median -11.7× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31